WASHINGTON — Trump administration officials are asking India to lift restrictions to give the U.S. access to pharmaceutical ingredients to produce a range of drugs amid fears of a U.S. drug supply shortage prompted by the coronavirus outbreak, three sources familiar with the matter told NBC News.
The two governments are holding discussions aimed at easing new restrictions on pharmaceutical exports from India, which New Delhi introduced to ensure that the country would have medicine needed to handle the pandemic inside its borders, the sources said.
With the coronavirus potentially disrupting the global supply chain for medicine, India earlier this month restricted the export of 26 pharmaceutical ingredients and the medicines made from them, including acetaminophen — a common pain reliever. India, the world’s leading supplier of generic drugs, is a key source for active pharmaceutical ingredients used to produce a range of medicines.
Full coverage of the coronavirus outbreak